Thermo Fisher crushed Q2 expectations with $6.03 EPS and nearly $12 billion in revenue, signaling strong growth and efficient cash flow management. Their stock surged nearly 10%—a rare move for the typically steady company—showing investor excitement. While still down year-to-date, the stock remains resilient over the past five years, reinforcing its long-term appeal.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
